{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:13:37Z","timestamp":1791278017756,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010466","name":"Chancellerie des Universit\u00e9s de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010466","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejphar.2011.10.027","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T08:56:57Z","timestamp":1319792217000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells"],"prefix":"10.1016","volume":"674","author":[{"given":"Vinciane","family":"Saint-Criq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Ruffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Rebeyrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tabary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.10.027_bb0005","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.50.5.1805-1812.2006","article-title":"Novel effects of azithromycin on tight junction proteins in human airway epithelia","volume":"50","author":"Asgrimsson","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0010","first-page":"CD001915","article-title":"Inhaled corticosteroids for cystic fibrosis","author":"Balfour-Lynn","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0015","first-page":"343","article-title":"Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK 1\/2, JNK and NF-kB activation in a cystic fibrosis epithelial cell line","volume":"291","author":"Blau","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/thx.51.10.1065","article-title":"Diffuse panbronchiolitis in an Asian immigrant","volume":"51","author":"Brugiere","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/AAC.01142-06","article-title":"Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells","volume":"51","author":"Cigana","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbrc.2006.09.132","article-title":"Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells","volume":"350","author":"Cigana","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1043661802002384","article-title":"Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily","volume":"46","author":"Di Paolo","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0040","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI2865","article-title":"Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells","volume":"101","author":"DiMango","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-277X.2004.00561.x","article-title":"Advice available on the Internet for people with coeliac disease: an evaluation of the quality of websites","volume":"17","author":"England","year":"2004","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pupt.2009.03.002","article-title":"Effects of prolonged use of azithromycin in patients with cystic fibrosis: A meta-analysis","volume":"22","author":"Florescu","year":"2009","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0055","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.biocel.2008.02.002","article-title":"Airway epithelial cell inflammatory signalling in cystic fibrosis","volume":"40","author":"Jacquot","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0060","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1128\/iai.65.12.5176-5183.1997","article-title":"Altered cytokine production by cystic fibrosis tracheal gland serous cells","volume":"65","author":"Kammouni","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1465-9921-7-134","article-title":"Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice","volume":"7","author":"Legssyer","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0070","first-page":"241","article-title":"Bronchial epithelial cell-cytokine interactions in airway inflammation","volume":"43","author":"Levine","year":"1995","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.110.171561","article-title":"Macrolide antibiotics inhibit mucus secretion and calcium entry in Swine airway submucosal mucous gland cells","volume":"336","author":"Lu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbrc.2007.03.141","article-title":"Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling","volume":"357","author":"Muselet-Charlier","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0085","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/01902140802534967","article-title":"Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells","volume":"35","author":"Oliynyk","year":"2009","journal-title":"Exp. Lung. Res."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0095","doi-asserted-by":"crossref","first-page":"L383","DOI":"10.1152\/ajplung.00403.2005","article-title":"CFTR inhibition mimics the cystic fibrosis inflammatory profile","volume":"292","author":"Perez","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0100","doi-asserted-by":"crossref","first-page":"L25","DOI":"10.1152\/ajplung.00256.2010","article-title":"The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia","volume":"300","author":"Pezzulo","year":"2011","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.2005.042564","article-title":"Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis","volume":"60","author":"Raia","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0110","doi-asserted-by":"crossref","first-page":"e5806","DOI":"10.1371\/journal.pone.0005806","article-title":"Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia","volume":"4","author":"Ribeiro","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/jpet.107.135186","article-title":"Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1\/2 and c-Jun-NH2-terminal kinase signaling","volume":"326","author":"Roque","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0120","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0125","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1128\/AAC.01403-10","article-title":"Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients","volume":"55","author":"Saint-Criq","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000196514","article-title":"Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy","volume":"63","author":"Sakito","year":"1996","journal-title":"Respiration"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0140","doi-asserted-by":"crossref","first-page":"L75","DOI":"10.1152\/ajplung.00093.2005","article-title":"Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells","volume":"290","author":"Shinkai","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymgme.2005.10.021","article-title":"Serum proteomic signature for cystic fibrosis using an antibody microarray platform","volume":"87","author":"Srivastava","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00089407","article-title":"Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells","volume":"34","author":"Stamatiou","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0160","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cellsig.2005.06.004","article-title":"Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells","volume":"18","author":"Tabary","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9440(10)65143-7","article-title":"Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells","volume":"155","author":"Tabary","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0170","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.4049\/jimmunol.164.6.3377","article-title":"High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the I kappa B kinase alpha pathway in response to extracellular NaCl content","volume":"164","author":"Tabary","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0175","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0002-9440(10)65633-7","article-title":"Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro","volume":"153","author":"Tabary","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0180","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1164\/rccm.200402-200OC","article-title":"Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection","volume":"170","author":"Tsai","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2011.10.027_bb0190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2011.10.027_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1165\/ajrcmb\/4.4.313","article-title":"A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection","volume":"4","author":"Zeitlin","year":"1991","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911013951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911013951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:14:40Z","timestamp":1757974480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911013951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014299911013951"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.027","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}